Literature DB >> 15852479

Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant with acute monoblastic leukemia (AML-M5).

Monika Wilda, Antje Vega Perez, Jochen Bruch, Wilhelm Woessmann, Markus Metzler, Uta Fuchs, Arndt Borkhardt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852479     DOI: 10.1002/gcc.20182

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


× No keyword cloud information.
  5 in total

1.  Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome.

Authors:  S E Bojesen; O Ammerpohl; A Weinhäusl; O A Haas; H Mettal; R M Bohle; A Borkhardt; U Fuchs
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

2.  GRAF1a is a brain-specific protein that promotes lipid droplet clustering and growth, and is enriched at lipid droplet junctions.

Authors:  Safa Lucken-Ardjomande Häsler; Yvonne Vallis; Helen E Jolin; Andrew N McKenzie; Harvey T McMahon
Journal:  J Cell Sci       Date:  2014-09-04       Impact factor: 5.285

Review 3.  The role of GTPase-activating protein ARHGAP26 in human cancers.

Authors:  Lingye Zhang; Anni Zhou; Shengtao Zhu; Li Min; Si Liu; Peng Li; Shutian Zhang
Journal:  Mol Cell Biochem       Date:  2021-10-30       Impact factor: 3.396

4.  GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice.

Authors:  Kaitlin C Lenhart; Thomas J O'Neill; Zhaokang Cheng; Rachel Dee; Alexis R Demonbreun; Jianbin Li; Xiao Xiao; Elizabeth M McNally; Christopher P Mack; Joan M Taylor
Journal:  Skelet Muscle       Date:  2015-08-21       Impact factor: 4.912

5.  Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Petter Brandal; Margaret Garnes; Anne Tierens; Sverre Heim
Journal:  Oncol Rep       Date:  2013-07-18       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.